Invenomic Capital Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.4M Buy
178,691
+8,985
+5% +$788K 0.92% 42
2026
Q1
$15.3M Buy
169,706
+35,848
+27% +$3.29M 0.7% 51
2025
Q4
$12M Buy
+133,858
New +$12.7M 0.56% 61
2025
Q3
– Sell
-89,088
Closed -$8.13M – 185
2025
Q2
$8.13M Buy
+89,088
New +$8.61M 0.46% 70

Other funds holding ZBH

Invenomic Capital Management's ZBH Position: Q2 2026 in Review

Invenomic Capital Management increased its Zimmer Biomet (ZBH) stake by 5.3% in Q2 2026, buying an estimated $788K and bringing the position to 178,691 shares worth $15.4M. The position accounts for 0.92% of the portfolio, ranked #42.

Invenomic Capital Management first reported a position in ZBH in Q2 2025 and has held it in 4 quarters since. 912 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Invenomic Capital Management held 178,691 shares of Zimmer Biomet worth $15.4M as of Q2 2026.
  • Invenomic Capital Management bought 8,985 Zimmer Biomet shares in Q2 2026, an estimated $788K.
  • Zimmer Biomet made up 0.92% of Invenomic Capital Management's portfolio in Q2 2026, its #42 holding.
  • Invenomic Capital Management first reported a position in Zimmer Biomet in Q2 2025 and has held it in 4 quarters since.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.